国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Novelty and Compliance of Oral Fast Dissolving Thin Film A Patient Friendly Dosage Form

Madiha Mushtaque, Iyad Naeem Muhmmad, Sidra Kanwal, Farah Khalid, Rida Masood, Aatka Ali

The oral fast-dissolving film is an advanced, patient compliant and novel delivery system. The acceptance of this ingenious dosage form is increasing day by day due to its several comparative advantages of being cost-benefit, rapid dissolving without water aid, as well as greatly compliant to both geriatric and pediatric patients in emergency conditions and specific diseases. Moreover, it is a worthwhile dosage form for the drug experiencing pre-systemic metabolism and lesser bioavailability. This review article covers history, advantages, disadvantages, limitations, ideal properties, classification, formulation consideration, method of manufacturing, quality parameters both in-vitro and in-vivo, advancement in technology, commercial trends and literature review of the previous work for oral fast dissolving films. It can be concluded that it one of the fastest-growing dosage forms holding a lot of potentials especially for commercial use due to its unique characteristics, novel attributes, competitive standing, and cost-adequacy.